Medicare Part D Reporting Requirements and Supporting Regulations in MMA Title I, Part 423, §423.514(a) (CMS-10185)

ICR 202106-0938-012

OMB: 0938-0992

Federal Form Document

Forms and Documents
Document
Name
Status
Supporting Statement A
2021-06-24
Supplementary Document
2021-06-22
Supplementary Document
2021-06-22
IC Document Collections
IC ID
Document
Title
Status
8853 Modified
ICR Details
0938-0992 202106-0938-012
Received in OIRA 202005-0938-013
HHS/CMS CM-CPC
Medicare Part D Reporting Requirements and Supporting Regulations in MMA Title I, Part 423, §423.514(a) (CMS-10185)
Revision of a currently approved collection   No
Regular 06/25/2021
  Requested Previously Approved
36 Months From Approved 12/31/2023
12,575 17,080
16,463 25,256
0 0

MMA provides CMS the statutory authority to require all Part D Sponsors (MA-PDs and PDPs) to report data related to their operational costs and services. These data will be analyzed for oversight and monitoring purposes, as well as potentially initiating other groups within the agency to perform functions such as fraud/waste/abuse investigations, audit activities, and compliance. Title I, Part 423, ?423.514 describes CMS' regulatory authority to establish reporting requirements for Part D sponsors. It is noted that each Part D plan sponsor must have an effective procedure to develop, compile, evaluate, and report to CMS, to its enrollees, and to the general public, at the times and in the manner that CMS requires, statistics in the following areas: (1) The cost of its operations. (2) The patterns of utilization of its services. (3) The availability, accessibility, and acceptability of its services. (4) Information demonstrating that the Part D plan sponsor has a fiscally sound operation. (5) Other matters that CMS may require. Subsection 423.505 of the MMA regulation establishes as a contract provision that Part D Sponsors must comply with the reporting requirements for submitting drug claims and related information to CMS.

Statute at Large: 1 Stat. 423
  
None

Not associated with rulemaking

  86 FR 14926 03/19/2021
86 FR 33301 06/24/2021
Yes

1
IC Title Form No. Form Name
Medicare Part D Reporting Requirements

  Total Request Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 12,575 17,080 0 -4,505 0 0
Annual Time Burden (Hours) 16,463 25,256 0 -8,793 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
Yes
Miscellaneous Actions
Burden has decreased due to the revision of several data elements in the Improving Drug Utilization Review Controls section. These revisions include modifying existing elements, adding new elements, and removing elements. The changes improve the quality and reliability.

$300,000
No
    No
    No
No
No
No
No
Stephan McKenzie 410 786-1943 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
06/25/2021


© 2024 OMB.report | Privacy Policy